Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
In a groundbreaking advancement in the fight against renal cancer, researchers have uncovered a pivotal molecular mechanism by which the nuclear receptor coactivator 7 (NCOA7) exerts a suppressive
The rapid development of ICI-based immunotherapy has ushered in a promising era for clear cell renal cell carcinoma (ccRCC). However, durable clinical responses remain limited to a subset of patients. Therefore, identifying novel predictive biomarkers and developing effective combination ...
Background: Type 2 papillary renal cell carcinoma (PRCC) is an aggressive subtype of renal cell carcinoma with a poor prognosis.
At ESMO 2025, a pooled analysis of 25 nivolumab trials provided new insights into checkpoint-inhibitor pneumonitis.
In a groundbreaking advance poised to reshape the landscape of preoperative cancer diagnostics, researchers have unveiled a sophisticated deep learning approach using CT scans to predict tumor staging
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer patients
... (ccRCC) – a type of kidney cancer – whose disease progressed following immunotherapy. Data from the LenCabo Phase II trial were presented today by ...
Objective To analyse imaging features and the differential diagnosis of eosinophilic solid and cystic renal cell carcinoma (ESC-RCC) . Methods The current study retrospectively reviewed the imaging features of seven patients (4 male, 3 female; age range: 25-70 years; median age: 46 years) ...
Renal cell carcinomas (RCCs) are the seventh most widespread histological cancer. Around 40% of patients die in RCC due to the disease development. Thus, this tumour is the most lethal malignant urological tumour. The histopathologic classification of RCC is vital for the prognosis, diagnosis, ...
In recent groundbreaking research, scientists have unearthed a compelling link between serum uric acid (SUA) levels and survival outcomes in patients battling metastatic renal cell carcinoma (mRCC)
In renal cell carcinoma (RCC), final analysis data from the CLEAR study comparing lenvatinib plus pembrolizumab versus sunitinib malate (Sutent ...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.